Summary of Product Characteristics
last updated on the eMC:
18/04/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 18/04/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and method of administration
-
Change to section 10 date of revision of the text
-
Correction of spelling/typing errors
|
| Date of revision of text on the SPC: 21-Feb-2011 |
| Legal Category: POM |
| Black Triangle (CHM):
YES |
Free-text change information supplied by the pharmaceutical company
|
|
In section 4.2 a revision to the description of the pre-treatment processes has been made.
In addition the a few minor editorial amendments to the SPC have been included.
In section 10 the last revision date of the text has been revised to correspondence with the date of the most recent Commission Decision as related to these changes.
|
|
Updated on 22/06/2010 and displayed until 18/04/2011
|
Reasons for adding or updating:
|
|
|
| Date of revision of text on the SPC: |
| Legal Category: POM |
| Black Triangle (CHM):
YES |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
